Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,646 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The role of frontline autologous stem cell transplantation for primary plasma cell leukemia: a retrospective multicenter study (KMM160).
Jung SH, Lee JJ, Kim K, Suh C, Yoon DH, Min CK, Sohn SK, Choi CW, Lee HS, Kim HJ, Shin HJ, Bang SM, Yoon SS, Park SK, Yhim HY, Kim MK, Jo JC, Mun YC, Lee JH, Kim JS; Korean Multiple Myeloma Working Party. Jung SH, et al. Among authors: suh c. Oncotarget. 2017 Jun 16;8(45):79517-79526. doi: 10.18632/oncotarget.18535. eCollection 2017 Oct 3. Oncotarget. 2017. PMID: 29108331 Free PMC article.
Outcome of adult severe or very severe aplastic anemia treated with immunosuppressive therapy compared with bone marrow transplantation: multicenter trial.
Ahn MJ, Choi JH, Lee YY, Choi IY, Kim IS, Yoon SS, Park SY, Kim BK, Suh C, Son HJ, Jung CW, Lee JH, Sung JM, Im SA, Oh D, Jung SY, Yoon HJ, Cho KS, Lee JA, Yuh YJ, Kim SR, Ki M. Ahn MJ, et al. Among authors: suh c. Int J Hematol. 2003 Aug;78(2):133-8. doi: 10.1007/BF02983381. Int J Hematol. 2003. PMID: 12953807 Clinical Trial.
High dose therapy followed by autologous peripheral blood stem cell transplantation as a first line treatment for multiple myeloma: a Korean Multicenter Study.
Bang SM, Cho EK, Suh C, Yoon SS, Seong CM, Cho KS, Kang YG, Park S, Ahn MJ, Park YS, Oh D, Kim HC, Jung CW, Kim S, Lee JH. Bang SM, et al. Among authors: suh c. J Korean Med Sci. 2003 Oct;18(5):673-8. doi: 10.3346/jkms.2003.18.5.673. J Korean Med Sci. 2003. PMID: 14555819 Free PMC article. Clinical Trial.
Improved therapeutic outcomes of DLBCL after introduction of rituximab in Korean patients.
Park YH, Lee JJ, Ryu MH, Kim SY, Kim DH, Do YR, Lee KH, Oh SJ, Kim YK, Suh CW, Heo DS, Ryoo BY, Kim JK, Song HS, Lee WS, Kim HJ, Bang YJ, Yang SH, Sohn SK, Kang YK; Lymphoma Study Division of the Korean Cancer Study Group. Park YH, et al. Among authors: suh cw. Ann Hematol. 2006 Apr;85(4):257-62. doi: 10.1007/s00277-005-0060-6. Epub 2006 Jan 17. Ann Hematol. 2006. PMID: 16416337
1,646 results